Cataract Clinical Trial
Official title:
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
With increasing demands of patients concerning refractive outcome after cataract surgery,
toric intraocular lenses (IOLs) that correct corneal astigmatism have been introduced more
widely to cataract surgery. Originally toric IOLs were used mainly for patients with high
degrees of astigmatism, especially after corneal surgical procedures such as penetrating
keratoplasty. Since a couple of years, toric IOLs are available from numerous manufacturers
to correct lower amounts of astigmatism which are much more prevalent with about 30% having
a corneal astigmatism of 0.75D or more in the cataract population. This should result in
less spectacle dependence of patients due to the astigmatic correction.
The alternative method to reduce corneal astigmatism as part of cataract surgery is to make
incisions on the steeper axis of the cornea such as limbal relaxing incisions or an
additional clear corneal incision opposite (OCCI) to the main cataract opening. These
techniques are in use since more than 2 decades and are widely used in clinical routine. As
with toric IOLs, precise alignment of the cuts with the axis of astigmatism is essential.
The disadvantage of the incisional techniques is the variability of the effect between
patients since it depends on factors such as the extent of scaring of the cuts after surgery
as well as corneal thickness. The main advantage is the simplicity of the technique and the
lower cost.
Aim of this study is to compare toric IOL implantation and opposite clear corneal incision
during cataract surgery to correct corneal astigmatism.
Status | Completed |
Enrollment | 55 |
Est. completion date | December 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Cataract - Age 21 and older - Regular corneal astigmatism 1.0 up to 2.5 D - written informed consent prior to surgery Exclusion Criteria: - Relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract corneal scars, and other co-morbidity that could affect capsule bag stability ( e.g. Marfan syndrome) - Irregular corneal astigmatism on corneal topography |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Austria | Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital | Vienna |
Lead Sponsor | Collaborator |
---|---|
Vienna Institute for Research in Ocular Surgery |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | postoperative IOL rotation | 3 months and 9 months post-operatively | Yes | |
Primary | Postoperative residual astigmatism | 9 months post-operatively | No | |
Secondary | uncorrected distance visual acuity (UDVA) | 9 months post-operatively | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |